Medical ProductsCompany
C. R. Bard M&A Summary
C. R. Bard has acquired 24 companies of its own. A total of 4 acquisitions came from private equity firms. It has also divested 1 asset.
C. R. Bard’s largest acquisition to date was in 2013, when it acquired Rochester Medical for $262M. It’s largest disclosed sale occurred in 2013, when it sold Bard EP to Boston Scientific for $275M. C. R. Bard has acquired in 10 different US states, and 2 countries. The Company’s most targeted sectors include medical products (79%) and healthcare services (18%).
C. R. Bard Ownership
Who owns C. R. Bard?
C. R. Bard is owned by Becton Dickinson. It was acquired on April 23, 2017.
C. R. Bard Business Overview
Where is C. R. Bard headquartered?
C. R. Bard is headquartered in Murray Hill, New Jersey.
What is C. R. Bard’s revenue?
C. R. Bard disclosed revenue of 3,714M USD for 2016 and 3,416M USD for 2015.
How many employees does C. R. Bard have?
C. R. Bard has 14,900 employees.
What sector is C. R. Bard in?
C. R. Bard is a medical products company.
When was C. R. Bard founded?
C. R. Bard was founded in 1907.
M&A Summary
-
M&A Total Activity24
- M&A Buy Activity23
- M&A Sell Activity1
- Total Sectors Invested 3
- Total Countries Invested 2
- M&A Buy/Sell Connections 5
Unlimited Searches
